selected publications
- KLRG1, Another Opportunity for a Breakthrough in MTCL. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Academic Article GET IT
- Approach to High-Risk Multiple Myeloma. Hematology/oncology clinics of North America. 2024 Review GET IT
-
On the Precipice of a "Rituximab-Like" Era for T-Cell Lymphomas?.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2023
Editorial Article
GET IT
Times cited: 1 -
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2023
Academic Article
GET IT
Times cited: 6 -
Novel agents in relapsed/refractory diffuse large B-cell lymphoma.
Hematological oncology.
2023
Review
GET IT
Times cited: 2 -
Polatuzumab vedotin in relapsed / refractory aggressive B-cell lymphoma.
Expert review of anticancer therapy.
2022
Academic Article
GET IT
Times cited: 1 - HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. Blood advances. 2021 Academic Article GET IT
-
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood.
2021
Academic Article
GET IT
Times cited: 9 -
Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma.
British journal of haematology.
2018
Review
GET IT
Times cited: 15 -
Novel Approaches in Waldenström Macroglobulinemia.
Hematology/oncology clinics of North America.
2018
Review
GET IT
Times cited: 3 -
Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia and lymphoma.
Clinical advances in hematology & oncology : H&O.
2016
Review
GET IT
Times cited: 10 -
Ibrutinib in previously treated Waldenström's macroglobulinemia.
The New England journal of medicine.
2015
Academic Article
GET IT
Times cited: 544 -
Hospital room sterilization using far-ultraviolet radiation: a pilot evaluation of the Sterilray device in an active hospital setting.
Infection control and hospital epidemiology.
2013
Academic Article
GET IT
Times cited: 1 -
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
The New England journal of medicine.
2013
Academic Article
GET IT
Times cited: 454 -
Integration of patient-specific paranasal sinus computed tomographic data into a virtual surgical environment.
American journal of rhinology & allergy.
2009
Academic Article
GET IT
Times cited: 31